TreeWAS – Variant ID: rs220519

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
I42.0 Dilated cardiomyopathy	0.000	0.833	0.167
I42 Cardiomyopathy	0.000	0.837	0.163
I42.1 Obstructive hypertrophic cardiomyopathy	0.000	0.843	0.157
I42.2 Other hypertrophic cardiomyopathy	0.000	0.853	0.147
I42.6 Alcoholic cardiomyopathy	0.000	0.857	0.143
I42.9 Cardiomyopathy, unspecified	0.000	0.858	0.142
I42.7 Cardiomyopathy due to drugs and other external agents	0.000	0.869	0.131
I42.3 Endomyocardial (eosinophilic) disease	0.000	0.883	0.117
I42.5 Other restrictive cardiomyopathy	0.000	0.887	0.113
I42.4 Endocardial fibroelastosis	0.000	0.901	0.099
I42.8 Other cardiomyopathies	0.000	0.916	0.084
Z36.3 Antenatal screening for malformations using ultrasound and other physical methods	0.000	0.965	0.035
Z36.0 Antenatal screening for chromosomal anomalies	0.000	0.965	0.035
Z36 Antenatal screening	0.000	0.966	0.034
Z36.9 Antenatal screening, unspecified	0.000	0.967	0.033
H02.4 Ptosis of eyelid	0.000	0.968	0.032
Z36.1 Antenatal screening for raised alphafetoprotein level	0.000	0.973	0.027
Z36.4 Antenatal screening for foetal growth retardation using ultrasound and other physical methods	0.000	0.973	0.027
Z36.5 Antenatal screening for isoimmunisation	0.000	0.975	0.024
H61.0 Perichondritis of external ear	0.000	0.982	0.018
Z36.2 Other antenatal screening based on amniocentesis	0.000	0.983	0.016
Z36.8 Other antenatal screening	0.000	0.990	0.009
M48.07 Spinal stenosis (Lumbosacral region)	0.000	0.991	0.009
S42.00 Fracture of clavicle (closed)	0.008	0.992	0.000
H16.0 Corneal ulcer	0.008	0.992	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.008	0.992	0.000
K82.4 Cholesterolosis of gallbladder	0.000	0.993	0.007
T78.3 Angioneurotic oedema	0.007	0.993	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.007	0.993	0.000
C92.0 Acute myeloid leukaemia	0.007	0.993	0.000
N75.0 Cyst of Bartholin's gland	0.006	0.994	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.006	0.994	0.000
I38 Endocarditis, valve unspecified	0.006	0.994	0.000
N76.4 Abscess of vulva	0.006	0.994	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.006	0.994	0.000
H61 Other disorders of external ear	0.000	0.994	0.006
C92 Myeloid leukaemia	0.006	0.994	0.000
L91.0 Keloid scar	0.006	0.994	0.000
S32.30 Fracture of ilium (closed)	0.000	0.994	0.006
C83.0 Small cell (diffuse)	0.006	0.994	0.000
S89.9 Unspecified injury of lower leg	0.000	0.994	0.006
N70.1 Chronic salpingitis and oophoritis	0.005	0.995	0.000
C92.7 Other myeloid leukaemia	0.005	0.995	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.005	0.995	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.005	0.995	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.005	0.995	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.005	0.995	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.005	0.995	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.005	0.995	0.000
T44.0 Anticholinesterase agents	0.005	0.995	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.005	0.995	0.000
C92.4 Acute promyelocytic leukaemia	0.005	0.995	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.005	0.995	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.005	0.995	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.005	0.995	0.000
N94.6 Dysmenorrhoea, unspecified	0.000	0.995	0.005
T36-T50 Poisoning by drugs, medicaments and biological substances	0.005	0.995	0.000
H61.3 Acquired stenosis of external ear canal	0.000	0.995	0.005
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.005	0.995	0.000
K72.0 Acute and subacute hepatic failure	0.005	0.995	0.000
C92.1 Chronic myeloid leukaemia	0.005	0.995	0.000
C83.7 Burkitt's tumour	0.005	0.995	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.005	0.995	0.000
C92.5 Acute myelomonocytic leukaemia	0.005	0.995	0.000
T50.8 Diagnostic agents	0.005	0.995	0.000
H61.1 Non-infective disorders of pinna	0.000	0.995	0.005
T36 Poisoning by systemic antibiotics	0.005	0.995	0.000
L57.8 Other skin changes due to chronic exposure to nonionising radiation	0.000	0.995	0.005
S62.61 Fracture of other finger (open)	0.005	0.995	0.000
N81.4 Uterovaginal prolapse, unspecified	0.000	0.995	0.005
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.004	0.995	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.004	0.995	0.000
C92.3 Myeloid sarcoma	0.004	0.995	0.000
C92.2 Subacute myeloid leukaemia	0.004	0.995	0.000
H16 Keratitis	0.004	0.996	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.004	0.996	0.000
C83.5 Lymphoblastic (diffuse)	0.004	0.996	0.000
T47.6 Antidiarrhoeal drugs	0.004	0.996	0.000
C91 Lymphoid leukaemia	0.004	0.996	0.000
T36.0 Penicillins	0.004	0.996	0.000
L91.8 Other hypertrophic disorders of skin	0.004	0.996	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.004	0.996	0.000
L91 Hypertrophic disorders of skin	0.004	0.996	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.004	0.996	0.000
C83.6 Undifferentiated (diffuse)	0.004	0.996	0.000
C83.4 Immunoblastic (diffuse)	0.004	0.996	0.000
C83.2 Mixed small and large cell (diffuse)	0.004	0.996	0.000
N70 Salpingitis and oophoritis	0.004	0.996	0.000
H16.8 Other keratitis	0.004	0.996	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.004	0.996	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.004	0.996	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.004	0.996	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.004	0.996	0.000
M54.46 Lumbago with sciatica (Lumbar region)	0.004	0.996	0.000
C91.9 Lymphoid leukaemia, unspecified	0.004	0.996	0.000
H16.2 Keratoconjunctivitis	0.004	0.996	0.000
T36.8 Other systemic antibiotics	0.004	0.996	0.000
T50.7 Analeptics and opioid receptor antagonists	0.004	0.996	0.000
T50.5 Appetite depressants	0.004	0.996	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.004	0.996	0.000
T50.1 Loop [high-ceiling] diuretics	0.004	0.996	0.000
T50.0 Mineralocorticoids and their antagonists	0.004	0.996	0.000
S42.0 Fracture of clavicle	0.004	0.996	0.000
H61.9 Disorder of external ear, unspecified	0.000	0.996	0.004
C91.0 Acute lymphoblastic leukaemia	0.004	0.996	0.000
T47.2 Stimulant laxatives	0.004	0.996	0.000
G95.2 Cord compression, unspecified	0.004	0.996	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.004	0.996	0.000
C83.1 Small cleaved cell (diffuse)	0.004	0.996	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.004	0.996	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.004	0.996	0.000
T47.7 Emetics	0.004	0.996	0.000
T47.5 Digestants	0.004	0.996	0.000
T47.3 Saline and osmotic laxatives	0.004	0.996	0.000
T50.4 Drugs affecting uric acid metabolism	0.004	0.996	0.000
H16.3 Interstitial and deep keratitis	0.004	0.996	0.000
T36.4 Tetracyclines	0.004	0.996	0.000
T47.4 Other laxatives	0.004	0.996	0.000
T45.5 Anticoagulants	0.004	0.996	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.004	0.996	0.000
T36.3 Macrolides	0.004	0.996	0.000
C15.9 Oesophagus, unspecified	0.000	0.996	0.004
F81.9 Developmental disorder of scholastic skills, unspecified	0.004	0.996	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.003	0.996	0.000
C91.5 Adult T-cell leukaemia	0.004	0.996	0.000
C91.4 Hairy-cell leukaemia	0.004	0.996	0.000
T36.9 Systemic antibiotic, unspecified	0.003	0.996	0.000
T36.7 Antifungal antibiotics, systemically used	0.003	0.996	0.000
T36.6 Rifamycins	0.003	0.996	0.000
T36.5 Aminoglycosides	0.003	0.996	0.000
T36.2 Chloramphenicol group	0.003	0.996	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.003	0.996	0.000
T47.0 Histamine H(2)-receptor antagonists	0.003	0.996	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.003	0.996	0.000
C95 Leukaemia of unspecified cell type	0.003	0.996	0.000
H61.8 Other specified disorders of external ear	0.000	0.997	0.003
C92.9 Myeloid leukaemia, unspecified	0.003	0.997	0.000
H16.1 Other superficial keratitis without conjunctivitis	0.003	0.997	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.003	0.997	0.000
N76 Other inflammation of vagina and vulva	0.003	0.997	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.003	0.997	0.000
C88 Malignant immunoproliferative diseases	0.003	0.997	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.003	0.997	0.000
T86.8 Failure and rejection of other transplanted organs and tissues	0.003	0.997	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.997	0.000
N70.0 Acute salpingitis and oophoritis	0.003	0.997	0.000
C94 Other leukaemias of specified cell type	0.003	0.997	0.000
H16.4 Corneal neovascularisation	0.003	0.997	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.003	0.997	0.000
T41.2 Other and unspecified general anaesthetics	0.003	0.997	0.000
N76.1 Subacute and chronic vaginitis	0.003	0.997	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.003	0.997	0.000
C91.7 Other lymphoid leukaemia	0.003	0.997	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.003	0.997	0.000
C91.3 Prolymphocytic leukaemia	0.003	0.997	0.000
C91.2 Subacute lymphocytic leukaemia	0.003	0.997	0.000
L91.9 Hypertrophic disorder of skin, unspecified	0.003	0.997	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.003	0.997	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.997	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.003	0.997	0.000
N75 Diseases of Bartholin's gland	0.003	0.997	0.000
T38.0 Glucocorticoids and synthetic analogues	0.003	0.997	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
T48.5 Anti-common-cold drugs	0.003	0.997	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.003	0.997	0.000
N70.9 Salpingitis and oophoritis, unspecified	0.003	0.997	0.000
S89 Other and unspecified injuries of lower leg	0.000	0.997	0.003
C95.9 Leukaemia, unspecified	0.003	0.997	0.000
T38.9 Other and unspecified hormone antagonists	0.003	0.997	0.000
T38.7 Androgens and anabolic congeners	0.003	0.997	0.000
T38.5 Other oestrogens and progestogens	0.003	0.997	0.000
T38.4 Oral contraceptives	0.003	0.997	0.000
T38.2 Antithyroid drugs	0.003	0.997	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.003	0.997	0.000
T48.4 Expectorants	0.003	0.997	0.000
T48.3 Antitussives	0.003	0.997	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.003	0.997	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.003	0.997	0.000
T48.0 Oxytocic drugs	0.003	0.997	0.000
T41.5 Therapeutic gases	0.003	0.997	0.000
T41.4 Anaesthetic, unspecified	0.003	0.997	0.000
T41.3 Local anaesthetics	0.003	0.997	0.000
T41.1 Intravenous anaesthetics	0.003	0.997	0.000
T41.0 Inhaled anaesthetics	0.003	0.997	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.003	0.997	0.000
T46.7 Peripheral vasodilators	0.003	0.997	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.003	0.997	0.000
T49.9 Topical agent, unspecified	0.003	0.997	0.000
T49.8 Other topical agents	0.003	0.997	0.000
T49.7 Dental drugs, topically applied	0.003	0.997	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.003	0.997	0.000
T49.5 Ophthalmological drugs and preparations	0.003	0.997	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.003	0.997	0.000
T49.3 Emollients, demulcents and protectants	0.003	0.997	0.000
T49.2 Local astringents and local detergents	0.003	0.997	0.000
T49.1 Antipruritics	0.003	0.997	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.003	0.997	0.000
H60-H62 Diseases of external ear	0.000	0.997	0.003
T37.2 Antimalarials and drugs acting on other blood protozoa	0.003	0.997	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.003	0.997	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.003	0.997	0.000
C93 Monocytic leukaemia	0.003	0.997	0.000
L43.9 Lichen planus, unspecified	0.003	0.997	0.000
C86 Other specified types of T/NK-cell lymphoma	0.003	0.997	0.000
L56.8 Other specified acute skin changes due to ultraviolet radiation	0.000	0.997	0.003
S42.01 Fracture of clavicle (open)	0.003	0.997	0.000
T38.1 Thyroid hormones and substitutes	0.003	0.997	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.003	0.997	0.000
E07.9 Disorder of thyroid, unspecified	0.000	0.997	0.003
T45.9 Primarily systemic and haematological agent, unspecified	0.003	0.997	0.000
T45.8 Other primarily systemic and haematological agents	0.003	0.997	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.003	0.997	0.000
T45.6 Fibrinolysis-affecting drugs	0.003	0.997	0.000
T45.4 Iron and its compounds	0.003	0.997	0.000
T45.3 Enzymes, not elsewhere classified	0.003	0.997	0.000
T86.0 Bone-marrow transplant rejection	0.003	0.997	0.000
L53.9 Erythematous condition, unspecified	0.003	0.997	0.000
Q79.6 Ehlers-Danlos syndrome	0.000	0.997	0.003
T40.6 Other and unspecified narcotics	0.003	0.997	0.000
S32.3 Fracture of ilium	0.000	0.997	0.003
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.003	0.997	0.000
T37.5 Antiviral drugs	0.003	0.997	0.000
T37.4 Anthelminthics	0.003	0.997	0.000
T37.3 Other antiprotozoal drugs	0.003	0.997	0.000
T37.1 Antimycobacterial drugs	0.003	0.997	0.000
T37.0 Sulphonamides	0.003	0.997	0.000
N76.0 Acute vaginitis	0.003	0.997	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.003	0.997	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.003	0.997	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.003	0.997	0.000
M43.02 Spondylolysis (Cervical region)	0.000	0.997	0.003
C84.0 Mycosis fungoides	0.003	0.997	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.003	0.997	0.000
C95.0 Acute leukaemia of unspecified cell type	0.003	0.997	0.000
C95.7 Other leukaemia of unspecified cell type	0.003	0.997	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.003	0.997	0.000
T46.1 Calcium-channel blockers	0.003	0.997	0.000
C94.4 Acute panmyelosis	0.003	0.997	0.000
T45.2 Vitamins, not elsewhere classified	0.003	0.997	0.000
T42.0 Hydantoin derivatives	0.003	0.997	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.003	0.997	0.000
C88.7 Other malignant immunoproliferative diseases	0.003	0.997	0.000
C88.3 Immunoproliferative small intestinal disease	0.003	0.997	0.000
C88.2 Gamma heavy chain disease	0.003	0.997	0.000
C88.1 Alpha heavy chain disease	0.003	0.997	0.000
S89.8 Other specified injuries of lower leg	0.000	0.997	0.003
T46.5 Other antihypertensive drugs, not elsewhere classified	0.003	0.997	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.003	0.997	0.000
H62 Disorders of external ear in diseases classified elsewhere	0.000	0.997	0.003
C94.7 Other specified leukaemias	0.002	0.997	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.002	0.997	0.000
C94.5 Acute myelofibrosis	0.002	0.997	0.000
C94.3 Mast cell leukaemia	0.002	0.997	0.000
C94.2 Acute megakaryoblastic leukaemia	0.002	0.997	0.000
C94.1 Chronic erythraemia	0.002	0.997	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.002	0.997	0.000
N04.1 Focal and segmental glomerular lesions	0.000	0.997	0.003
C90.3 Solitary plasmacytoma	0.003	0.997	0.000
N75.8 Other diseases of Bartholin's gland	0.003	0.997	0.000
N76.5 Ulceration of vagina	0.003	0.997	0.000
H60.9 Otitis externa, unspecified	0.000	0.997	0.003
C45.0 Mesothelioma of pleura	0.000	0.997	0.003
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.003	0.997	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.002	0.997	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.002	0.997	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.002	0.997	0.000
C84.3 Lymphoepithelioid lymphoma	0.002	0.997	0.000
C84.2 T-zone lymphoma	0.002	0.997	0.000
C84.1 Sezary's diease	0.002	0.997	0.000
H50.1 Divergent concomitant strabismus	0.003	0.997	0.000
N76.3 Subacute and chronic vulvitis	0.003	0.997	0.000
T40.5 Cocaine	0.002	0.997	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.002	0.997	0.000
C96.8 Histiocytic sarcoma	0.002	0.997	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.002	0.997	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.002	0.997	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.002	0.997	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.002	0.997	0.000
C96.3 True histiocytic lymphoma	0.002	0.997	0.000
C96.2 Malignant mast cell tumour	0.002	0.997	0.000
C96.1 Malignant histiocytosis	0.002	0.997	0.000
C96.0 Letterer-Siwe disease	0.002	0.997	0.000
N75.9 Disease of Bartholin's gland, unspecified	0.002	0.997	0.000
S89.7 Multiple injuries of lower leg	0.000	0.997	0.002
S89.1 Other specified injuries of lower leg	0.000	0.997	0.002
S89.0 Multiple injuries of lower leg	0.000	0.997	0.002
T40.1 Heroin	0.002	0.997	0.000
C84.4 Peripheral T-cell lymphoma	0.002	0.997	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.002	0.997	0.000
M23.35 Other meniscus derangements (Posterior horn of lateral meniscus)	0.000	0.997	0.003
M80.90 Unspecified osteoporosis with pathological fracture (Multiple sites)	0.003	0.997	0.000
C49.2 Connective and soft tissue of lower limb, including hip	0.003	0.997	0.000
T40.3 Methadone	0.002	0.997	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.002	0.997	0.000
T42.2 Succinimides and oxazolidinediones	0.002	0.997	0.000
H60 Otitis externa	0.000	0.997	0.003
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.002	0.997	0.000
T40.8 Lysergide [LSD]	0.002	0.997	0.000
T40.7 Cannabis (derivatives)	0.002	0.997	0.000
T40.0 Opium	0.002	0.997	0.000
T42.3 Barbiturates	0.002	0.997	0.000
T45.0 Antiallergic and antiemetic drugs	0.002	0.997	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.002	0.997	0.000
C86.4 Blastic NK-cell lymphoma	0.002	0.997	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.002	0.997	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.002	0.997	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.002	0.997	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.002	0.997	0.000
C90.2 Plasmacytoma, extramedullary	0.002	0.997	0.000
C93.9 Monocytic leukaemia, unspecified	0.002	0.997	0.000
C93.7 Other monocytic leukaemia	0.002	0.997	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.002	0.997	0.000
C93.2 Subacute monocytic leukaemia	0.002	0.997	0.000
C93.0 Acute monocytic leukaemia	0.002	0.997	0.000
T86 Failure and rejection of transplanted organs and tissues	0.002	0.998	0.000
N76.6 Ulceration of vulva	0.002	0.998	0.000
C45.7 Mesothelioma of other sites	0.000	0.998	0.002
H62.0 Otitis externa in bacterial diseases classified elsewhere	0.000	0.998	0.002
L56 Other acute skin changes due to ultraviolet radiation	0.000	0.998	0.002
T42.1 Iminostilbenes	0.002	0.998	0.000
T86.4 Liver transplant failure and rejection	0.002	0.998	0.000
M43.09 Spondylolysis (Site unspecified)	0.000	0.998	0.002
N70-N77 Inflammatory diseases of female pelvic organs	0.002	0.998	0.000
H16.9 Keratitis, unspecified	0.002	0.998	0.000
T82.8 Other complications of cardiac and vascular prosthetic devices, implants and grafts	0.002	0.998	0.000
H60.3 Other infective otitis externa	0.000	0.998	0.002
L56.9 Acute skin change due to ultraviolet radiation, unspecified	0.000	0.998	0.002
T37.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
H61.2 Impacted cerumen	0.000	0.998	0.002
M43.0 Spondylolysis	0.000	0.998	0.002
O81.4 Vacuum extractor delivery	0.000	0.998	0.002
T82.7 Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts	0.002	0.998	0.000
S32.31 Fracture of ilium (open)	0.000	0.998	0.002
C86.5 Angioimmunoblastic T-cell lymphoma	0.002	0.998	0.000
C93.1 Chronic monocytic leukaemia	0.002	0.998	0.000
N04 Nephrotic syndrome	0.000	0.998	0.002
C90.1 Plasma cell leukaemia	0.002	0.998	0.000
N76.8 Other specified inflammation of vagina and vulva	0.002	0.998	0.000
H60.5 Acute otitis externa, non-infective	0.000	0.998	0.002
H62.8 Other disorders of external ear in diseases classified elsewhere	0.000	0.998	0.002
H62.4 Otitis externa in other diseases classified elsewhere	0.000	0.998	0.002
H62.3 Otitis externa in other infectious and parasitic diseases classified elsewhere	0.000	0.998	0.002
H62.2 Otitis externa in mycoses	0.000	0.998	0.002
H62.1 Otitis externa in viral diseases classified elsewhere	0.000	0.998	0.002
F81 Specific developmental disorders of scholastic skills	0.002	0.998	0.000
S80.1 Contusion of other and unspecified parts of lower leg	0.000	0.998	0.002
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.002	0.998	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.002	0.998	0.000
N04.0 Minor glomerular abnormality	0.000	0.998	0.002
T45.1 Antineoplastic and immunosuppressive drugs	0.002	0.998	0.000
C15.4 Middle third of oesophagus	0.000	0.998	0.002
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.002	0.998	0.000
N04.9 Unspecified	0.000	0.998	0.002
M43.17 Spondylolisthesis (Lumbosacral region)	0.000	0.998	0.002
I60.1 Subarachnoid haemorrhage from middle cerebral artery	0.000	0.998	0.002
T86.9 Failure and rejection of unspecified transplanted organ and tissue	0.002	0.998	0.000
T86.3 Heart-lung transplant failure and rejection	0.002	0.998	0.000
T86.2 Heart transplant failure and rejection	0.002	0.998	0.000
V44.5 Driver injured in traffic accident	0.002	0.998	0.000
C45 Mesothelioma	0.000	0.998	0.002
L56.3 Solar urticaria	0.000	0.998	0.002
L56.2 Photocontact dermatitis [berloque dermatitis]	0.000	0.998	0.002
L56.1 Drug photoallergic response	0.000	0.998	0.002
L56.0 Drug phototoxic response	0.000	0.998	0.002
N04.2 Diffuse membranous glomerulonephritis	0.000	0.998	0.002
I60.9 Subarachnoid haemorrhage, unspecified	0.000	0.998	0.002
L57 Skin changes due to chronic exposure to nonionising radiation	0.000	0.998	0.002
N74 Female pelvic inflammatory disorders in diseases classified elsewhere	0.002	0.998	0.000
H50.2 Vertical strabismus	0.002	0.998	0.000
H60.4 Cholesteatoma of external ear	0.000	0.998	0.002
M43.05 Spondylolysis (Thoracolumbar region)	0.000	0.998	0.002
M43.04 Spondylolysis (Thoracic region)	0.000	0.998	0.002
M43.03 Spondylolysis (Cervicothoracic region)	0.000	0.998	0.002
M43.01 Spondylolysis (Occipito-atlanto-axial region)	0.000	0.998	0.002
M43.00 Spondylolysis (Multiple sites in spine)	0.000	0.998	0.002
C49.1 Connective and soft tissue of upper limb, including shoulder	0.002	0.998	0.000
C84.5 Other and unspecified T-cell lymphomas	0.002	0.998	0.000
O66.5 Failed application of vacuum extractor and forceps, unspecified	0.000	0.998	0.002
M43.08 Spondylolysis (Sacral and sacrococcygeal region)	0.000	0.998	0.002
N04.8 Other	0.000	0.998	0.002
N04.7 Diffuse crescentic glomerulonephritis	0.000	0.998	0.002
N04.6 Dense deposit disease	0.000	0.998	0.002
N04.5 Diffuse mesangiocapillary glomerulonephritis	0.000	0.998	0.002
N04.4 Diffuse endocapillary proliferative glomerulonephritis	0.000	0.998	0.002
N04.3 Diffuse mesangial proliferative glomerulonephritis	0.000	0.998	0.002
Z02.8 Other examinations for administrative purposes	0.002	0.998	0.000
J34.1 Cyst and mucocele of nose and nasal sinus	0.002	0.998	0.000
M47.96 Spondylosis, unspecified (Lumbar region)	0.000	0.998	0.002
C49 Malignant neoplasm of other connective and soft tissue	0.002	0.998	0.000
M43.07 Spondylolysis (Lumbosacral region)	0.000	0.998	0.002
H60.8 Other otitis externa	0.000	0.998	0.002
N03.9 Unspecified	0.000	0.998	0.002
M48.09 Spinal stenosis (Site unspecified)	0.000	0.998	0.002
Q85.9 Phakomatosis, unspecified	0.000	0.998	0.002
F81.8 Other developmental disorders of scholastic skills	0.002	0.998	0.000
F81.3 Mixed disorder of scholastic skills	0.002	0.998	0.000
F81.2 Specific disorder of arithmetical skills	0.002	0.998	0.000
F81.1 Specific spelling disorder	0.002	0.998	0.000
F81.0 Specific reading disorder	0.002	0.998	0.000
O64.0 Obstructed labour due to incomplete rotation of foetal head	0.002	0.998	0.000
M43.06 Spondylolysis (Lumbar region)	0.000	0.998	0.002
Q79 Congenital malformations of musculoskeletal system, not elsewhere classified	0.000	0.998	0.002
L56.4 Polymorphous light eruption	0.000	0.998	0.002
C15 Malignant neoplasm of oesophagus	0.000	0.998	0.002
C49.4 Connective and soft tissue of abdomen	0.002	0.998	0.000
H60.0 Abscess of external ear	0.000	0.998	0.002
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
C85.0 Lymphosarcoma	0.002	0.998	0.000
F52.2 Failure of genital response	0.000	0.998	0.002
K66.8 Other specified disorders of peritoneum	0.002	0.998	0.000
Q85.0 Neurofibromatosis (nonmalignant)	0.000	0.998	0.002
L57.9 Skin changes due to chronic exposure to nonionising radiation, unspecified	0.000	0.998	0.002
K11.1 Hypertrophy of salivary gland	0.000	0.998	0.002
N76.2 Acute vulvitis	0.002	0.998	0.000
C15.0 Cervical part of oesophagus	0.000	0.998	0.002
C49.3 Connective and soft tissue of thorax	0.002	0.998	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.002	0.998	0.000
I46.9 Cardiac arrest, unspecified	0.000	0.998	0.002
Q76.4 Other congenital malformations of spine, not associated with scoliosis	0.000	0.998	0.002
T78.0 Anaphylactic shock due to adverse food reaction	0.002	0.998	0.000
L43 Lichen planus	0.002	0.998	0.000
C45.2 Mesothelioma of pericardium	0.000	0.998	0.002
C45.1 Mesothelioma of peritoneum	0.000	0.998	0.002
M48.0 Spinal stenosis	0.000	0.998	0.002
T40.4 Other synthetic narcotics	0.002	0.998	0.000
H60.2 Malignant otitis externa	0.000	0.998	0.001
M54.4 Lumbago with sciatica	0.002	0.998	0.000
Q76.1 Klippel-Feil syndrome	0.000	0.998	0.002
S80.7 Multiple superficial injuries of lower leg	0.000	0.998	0.002
K72 Hepatic failure, not elsewhere classified	0.002	0.998	0.000
N03 Chronic nephritic syndrome	0.000	0.998	0.002
C81 Hodgkin's disease	0.002	0.998	0.000
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue	0.000	0.998	0.002
L57.3 Poikiloderma of Civatte	0.000	0.998	0.002
L57.2 Cutis rhomboidalis nuchae	0.000	0.998	0.002
L57.1 Actinic reticuloid	0.000	0.998	0.002
N74.8 Female pelvic inflammatory disorders in other diseases classified elsewhere	0.001	0.998	0.000
N74.4 Female chlamydial pelvic inflammatory disease	0.001	0.998	0.000
N74.3 Female gonococcal pelvic inflammatory disease	0.001	0.998	0.000
N74.2 Female syphilitic pelvic inflammatory disease	0.001	0.998	0.000
N74.1 Female tuberculous pelvic inflammatory disease	0.001	0.998	0.000
N74.0 Tuberculous infection of cervix uteri	0.001	0.998	0.000
M70.22 Olecranon bursitis-Upper arm	0.002	0.998	0.000
C49.6 Connective and soft tissue of trunk, unspecified	0.002	0.998	0.000
T43.6 Psychostimulants with abuse potential	0.002	0.998	0.000
M43.62 Torticollis-Cervical	0.000	0.998	0.002
I74.2 Embolism and thrombosis of arteries of the upper extremities	0.002	0.998	0.000
N03.1 Focal and segmental glomerular lesions	0.000	0.998	0.002
C49.8 Overlapping lesion of connective and soft tissue	0.002	0.998	0.000
L43.0 Hypertrophic lichen planus	0.002	0.998	0.000
L57.5 Actinic granuloma	0.000	0.998	0.002
Q79.1 Other congenital malformations of diaphragm	0.000	0.998	0.002
M54.49 Lumbago with sciatica (Site unspecified)	0.002	0.998	0.000
J84.9 Interstitial pulmonary disease, unspecified	0.002	0.998	0.000
T43.9 Psychotropic drug, unspecified	0.002	0.998	0.000
N77 Vulvovaginal ulceration and inflammation in diseases classified elsewhere	0.002	0.998	0.000
C45.9 Mesothelioma, unspecified	0.000	0.998	0.002
S80 Superficial injury of lower leg	0.000	0.998	0.002
C15.8 Overlapping lesion of oesophagus	0.000	0.998	0.001
C15.2 Abdominal part of oesophagus	0.000	0.998	0.001
C15.1 Thoracic part of oesophagus	0.000	0.998	0.001
C49.5 Connective and soft tissue of pelvis	0.001	0.998	0.000
C91.1 Chronic lymphocytic leukaemia	0.002	0.998	0.000
K73.2 Chronic active hepatitis, not elsewhere classified	0.002	0.998	0.000
M43.6 Torticollis	0.000	0.998	0.002
Q79.9 Congenital malformation of musculoskeletal system, unspecified	0.000	0.998	0.001
Q79.5 Other congenital malformations of abdominal wall	0.000	0.998	0.001
Q79.4 Prune belly syndrome	0.000	0.998	0.001
Q79.3 Gastroschisis	0.000	0.998	0.001
Q79.2 Exomphalos	0.000	0.998	0.001
Q79.0 Congenital diaphragmatic hernia	0.000	0.998	0.001
L58 Radiodermatitis	0.000	0.998	0.001
M80.88 Other osteoporosis with pathological fracture (Other)	0.002	0.998	0.000
D38.1 Trachea, bronchus and lung	0.002	0.998	0.000
H25.9 Senile cataract, unspecified	0.002	0.998	0.000
I23.8 Other current complications following acute myocardial infarction	0.000	0.998	0.002
K72.1 Chronic hepatic failure	0.001	0.998	0.000
N02.8 Other	0.000	0.998	0.002
Q44.6 Cystic disease of liver	0.002	0.998	0.000
S30.2 Contusion of external genital organs	0.000	0.998	0.002
S80.9 Superficial injury of lower leg, unspecified	0.000	0.998	0.002
T43.8 Other psychotropic drugs, not elsewhere classified	0.001	0.998	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.001	0.998	0.000
K42.0 Umbilical hernia with obstruction, without gangrene	0.002	0.998	0.000
M80.9 Unspecified osteoporosis with pathological fracture	0.002	0.998	0.000
N90.7 Vulvar cyst	0.002	0.998	0.000
R82.7 Abnormal findings on microbiological examination of urine	0.000	0.998	0.002
C49.9 Connective and soft tissue, unspecified	0.001	0.998	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.001	0.998	0.000
Z57.5 Occupational exposure to toxic agents in other industries	0.000	0.998	0.002
M43 Other deforming dorsopathies	0.000	0.998	0.002
Q76 Congenital malformations of spine and bony thorax	0.000	0.998	0.002
N00-N08 Glomerular diseases	0.000	0.998	0.002
M24.02 Loose body in joint (Upper arm)	0.002	0.998	0.000
M48.05 Spinal stenosis (Thoracolumbar region)	0.000	0.998	0.001
M48.03 Spinal stenosis (Cervicothoracic region)	0.000	0.998	0.001
M48.01 Spinal stenosis (Occipito-atlanto-axial region)	0.000	0.998	0.001
C81.0 Lymphocytic predominance	0.001	0.998	0.000
G80.0 Spastic cerebral palsy	0.000	0.998	0.001
H60.1 Cellulitis of external ear	0.000	0.998	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations